Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
Objective: to determine the efficiency of sequential (combined) therapy with rituximab (RTM) and belimumab (BLM) in patients with active systemic lupus erythematosus (SLE).Patients and methods. Twelve patients with true SLE having moderate-to-high activity were followed up. Six of them were noted to...
Saved in:
| Main Authors: | A. A. Mesnyankina, S. K. Solovyev, N. Yu. Nikishina, E. A. Aseeva, N. V. Demidova, E. L. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-11-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1066 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2023-10-01) -
Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01) -
THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2018-07-01) -
Long-term belimumab therapy in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2024-08-01) -
Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2019-03-01)